{"entity":{"type":"insider","cik":"0001652208","url":"/insider/0001652208","json_url":"/insider/0001652208.json","name":"Gulino Richard L.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":3,"first":"2017-01-05","last":"2018-03-02","span_basis":"filed_date"},"name_variants":[{"name":"Gulino Richard L.","source":"filing","n_filings":3,"first_seen":"2017-01-05","last_seen":"2018-03-02"}],"transactions":[{"id":6631907,"accession":"0001209191-18-015878","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-015878","line_url":"/filing/0001209191-18-015878#line-2","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001652208","owner_name":"Gulino Richard L.","owner_display_name":"Gulino Richard L.","owner_url":"/insider/0001652208","role":"Officer (SVP, General Counsel & Sec)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel & Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel & Sec.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3660.0,"shares_display":"3,660","price_per_share":18.7085,"price_display":"18.71","price_state":"stated","total_value":68473.11,"total_display":"68,473.11","total_whole":"68,473","shares_owned_after":115073.0,"shares_owned_after_display":"115,073","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-01","filed_date":"2018-03-02","scope":"insider"},{"id":6700186,"accession":"0001209191-18-002054","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-002054","line_url":"/filing/0001209191-18-002054#line-3","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001652208","owner_name":"Gulino Richard L.","owner_display_name":"Gulino Richard L.","owner_url":"/insider/0001652208","role":"Officer (SVP, General Counsel & Sec)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel & Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel & Sec.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10367.0,"shares_display":"10,367","price_per_share":15.1987,"price_display":"15.20","price_state":"stated","total_value":157564.9229,"total_display":"157,564.92","total_whole":"157,565","shares_owned_after":88733.0,"shares_owned_after_display":"88,733","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-02","filed_date":"2018-01-04","scope":"insider"},{"id":5059224,"accession":"0001209191-17-002214","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-002214","line_url":"/filing/0001209191-17-002214#line-3","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001652208","owner_name":"Gulino Richard L.","owner_display_name":"Gulino Richard L.","owner_url":"/insider/0001652208","role":"Officer (SVP, General Counsel & Sec)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel & Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel & Sec.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10900.0,"shares_display":"10,900","price_per_share":15.5128,"price_display":"15.51","price_state":"stated","total_value":169089.52,"total_display":"169,089.52","total_whole":"169,090","shares_owned_after":9100.0,"shares_owned_after_display":"9,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-03","filed_date":"2017-01-05","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001347178","name":"Vanda Pharmaceuticals Inc.","url":"/issuer/0001347178","role":"Officer (SVP, General Counsel & Sec)","n_filings":3,"first_seen":"2017-01-05","last_seen":"2018-03-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001652208","retrieved_at":"2026-08-24T11:29:19+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}